Theravance Biopharma aims to transform the treatment of serious lung diseases through the discovery and development of lung-selective medicines designed to maximize patient benefit while minimizing patient risk.
Our research is focused in the areas of inflammation and immunology, and our pipeline of internally discovered programs is targeted to address significant patient needs.
Theravance Biopharma is a place for collaborators and creative problem-solvers – people who thrive on applying insight and innovation to discovering novel medicines.
Our dedication to patients expands beyond the laboratory.
Our integrated team is committed to developing and providing the world with lung-selective medicines for serious lung diseases.
We leverage insight and innovation to transform the treatment of serious lung diseases.
